Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
About us
Contact
Links
About us
Contact
Links
Accordion Title
Accordion Content
more items +
Traders shouldn’t bet on another year of double-digit gains for U.S. stocks in 2025, analyst warns
Trump’s Bessent pick for Treasury boosts hopes for year-end stock-market rally
Retirees are facing financial strain as credit-card debt spikes
15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season
Ether’s not dead yet. Here are 3 ways a second Trump term could help it catch up to bitcoin’s rally.
My children don’t care about me. I’m 61 and want to rewrite my will. Where do I start?
Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals
Wall Street analyst slaps the highest MicroStrategy stock-price target yet — here’s why.
Procter & Gamble’s stock upgraded to buy as its China business is perking up
Wall Street targets for S&P 500 next year huddled in narrow range as Barclays hikes view
Quikrete bulks up even more ahead of potential construction boom by buying Summit Materials
Macy’s finds ‘erroneous’ accounting entries, leading to delay of earnings report
Traders shouldn’t bet on another year of double-digit gains for U.S. stocks in 2025, analyst warns
Trump’s Bessent pick for Treasury boosts hopes for year-end stock-market rally
Retirees are facing financial strain as credit-card debt spikes
15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season
Ether’s not dead yet. Here are 3 ways a second Trump term could help it catch up to bitcoin’s rally.
My children don’t care about me. I’m 61 and want to rewrite my will. Where do I start?
Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals
Wall Street analyst slaps the highest MicroStrategy stock-price target yet — here’s why.
Procter & Gamble’s stock upgraded to buy as its China business is perking up
Wall Street targets for S&P 500 next year huddled in narrow range as Barclays hikes view
Quikrete bulks up even more ahead of potential construction boom by buying Summit Materials
Macy’s finds ‘erroneous’ accounting entries, leading to delay of earnings report
How Apple could be an AI winner, says one venture-capital investor active in the sector
25-11-24
Apple has done research to run large language models with limited memory.
Share this on:
